Shababa Masoud

Shababa Masoud is a Scientist II at insitro as of April 2024, previously serving as Scientist and Manager of Preclinical Translational Sciences at Denali Therapeutics from February 2019 to February 2024. Expertise includes neurological diseases, with significant contributions as In Vivo Function Lead and Biomarker Technical Team Lead on regulatory submissions, publications, and patents. Earlier roles involved managing outsourced projects, collaborating on an in vivo study management tool, and conducting health outcomes research at Sunnybrook Health Sciences Center. Shababa possesses a Ph.D. in Pharmacology and Toxicology, alongside an Honors Bachelor of Science with Distinction in Toxicology and a minor in Economics from the University of Toronto. Accomplishments also span teaching, tutoring, and consulting for non-profits.